Media Advisory: Top Smoking Cessation Experts Meet in Ottawa
OTTAWA, Jan. 19, 2019 (GLOBE NEWSWIRE) -- National and international smoking cessation authorities are gathering in Ottawa today to attend the second and final day of the 11th Annual Ottawa Conference: State of the Art Clinical Approaches to Smoking Cessation, Canada's premier event promoting the latest ideas and evidence in clinical tobacco treatment, program development and smoking cessation research. This year's proceedings take place ahead of National Non-Smoking Week, January 20-26.
CONFERENCE DETAILS
WHAT: The 11th Annual Ottawa Conference: State of the Art Clinical Approaches to Smoking Cessation WHEN: January 18 and 19, 2019 WHERE: Shaw Centre, 55 Colonel By Dr, Ottawa, ON K1N 9J2
TODAY'S HOT TOPICS
Understanding and Treating Tobacco Dependence in Smokers with Mental Illness
OMSC to the Rescue: Lessons Learned from Implementing Smoking Cessation in Specialty Populations
Tobacco Cessation Programs in Canada's Far North: A Nunavut Perspective
Motivational Interviewing: Moving from Ambivalence to Change Talk
Federal Tobacco Control Strategy and Its Implication
Cannabis and the Heart: Getting Into and Out of the Weeds
Visit the OMSC website for detailed information including timings and locations of all proceedings.
TO COORDINATE INTERVIEWS WITH KEY SPOKESPERSONS, PLEASE CONTACT:
Leigh B. Morris Communications Officer University of Ottawa Heart Institute 613-316-6409 (cell) [email protected]
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...
StateHouse Holdings Inc. ("StateHouse" or the "Company") , a California-focused, vertically integrated cannabis company, today announced further to its press release dated April 15, 2024, that the Ontario Securities Commission (the "OSC") has denied...
Grifols, S.A. ("Grifols") (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines, today announces the filing of its Annual Report on Form 20-F for the fiscal year ended December 31,...
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:
On Thursday, the FDA posted a safety communication to inform the public and healthcare providers that the agency has required and...
Unifor expects to achieve the wage increases and benefit improvements awarded to Ontario OCHU-CUPE and SEIU Healthcare members by Arbitrator William Kaplan in a recent decision....